CTLA4 has a profound impact on the landscape of tumor-infiltrating lymphocytes with a high prognosis value in clear cell renal cell carcinoma (ccRCC)

BACKGROUND: Cytotoxic T-lymphocyte associated protein 4 (CTLA4) inhibitors have been shown to significantly prolong the overall survival (OS) in a wide range of cancers. However, its application in clear cell renal cell carcinoma (ccRCC) is limited due to the therapy response, and the prognostic val...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Cell Int
Principais autores: Liu, Shiyi, Wang, Feiyan, Tan, Wei, Zhang, Li, Dai, Fangfang, Wang, Yanqing, Fan, Yaqi, Yuan, Mengqin, Yang, Dongyong, Zheng, Yajing, Deng, Zhimin, Liu, Yeqiang, Cheng, Yanxiang
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Primary Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7590466/
https://ncbi.nlm.nih.gov/pubmed/33117084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-020-01603-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados